Skip to main content
. 2022 Sep 27;32(12):1768–1780. doi: 10.1111/sms.14235

TABLE 1.

Characteristics of the study population stratified according to prevalent depressive symptoms (yes/no) and incident depressive symptoms (yes/no)

Characteristic Total population at baseline (n = 5582) No prevalent depressive symptoms (n = 5354) Prevalent depressive symptoms (n = 228) p‐value Total population with follow‐up data (n = 5113) No incident depressive symptoms (n = 4549) Incident depressive symptoms (n = 564) p‐value
Sex (women), n (%) 2809 (50.3) 2674 (49.9) 135 (59.2) 0.006 2559 (50.0) 2256 (49.6) 303 (53.7) 0.064
Age (years) 59.9 ± 8.6 60.1 ± 8.6 56.5 ± 8.8 <0.001 60.1 ± 8.5 60.1 ± 8.5 59.9 ± 8.5 0.590
Education, n (%)
Low 1891 (33.9) 1793 (33.5) 98 (43.0) <0.001 1682 (32.9) 1455 (32.0) 227 (40.2) <0.001
Medium 1537 (27.5) 1467 (27.4) 70 (30.7) 1408 (27.5) 1253 (27.5) 155 (27.5)
High 2154 (38.6) 2094 (39.1) 60 (26.3) 2023 (39.6) 1841 (40.5) 182 (32.3)
Smoking, n (%) <0.001 <0.001
Never 2115 (37.9) 2048 (38.3) 67 (29.4) 1962 (38.4) 1783 (39.2) 179 (31.7)
Former 2793 (50.0) 2684 (50.1) 109 (47.8) 2573 (50.3) 2286 (50.3) 287 (50.9)
Current 674 (12.1) 622 (11.6) 52 (22.8) 578 (11.3) 480 (10.6) 98 (17.4)
Alcohol consumption, n (%) <0.001 <0.001
None 981 (17.6) 899 (16.8) 82 (36.0) 835 (16.3) 696 (15.3) 139 (24.6)
Low 3304 (59.2) 3.196 (59.7) 108 (47.4) 3052 (59.7) 2742 (60.3) 310 (55.0)
High 1297 (23.2) 1.259 (23.5) 38 (16.7) 1226 (24.0) 1111 (24.4) 115 (20.4)
Having a partner (yes), n (%) 4707 (84.4) 4.555 (85.1) 152 (66.7) <0.001 4.364 (85.4) 3.917 (86.2) 447 (79.3) <0.001
Energy intake (Kcal) 2128.3 ± 592.1 2127.9 ± 590.8 2138.4 ± 622.5 0.793 2126.4 ± 586.2 2124.7 ± 583.2 2140.1 ± 609.6 0.558
Body mass index (kg/m2) 26.9 ± 4.4 26.8 ± 4.3 28.5 ± 5.8 <0.001 26.8 ± 4.3 26.6 ± 4.1 27.9 ± 5.2 <0.001
Hypertension, n (%) 2989 (53.5) 2854 (53.3) 135 (59.2) 0.080 2721 (53.2) 2381 (52.3) 340 (60.3) <0.001
Total cholesterol‐to‐HDL cholesterol ratio, n (%) 3.6 ± 1.2 3.6 ± 1.2 3.8 ± 1.5 <0.001 3.6 ± 1.1 3.5 ± 1.1 3.7 ± 1.2 0.026
History of CVD, n (%) 928 (16.6) 875 (16.3) 53 (23.2) 0.006 828 (16.2) 715 (15.7) 113 (20.0) 0.009
Type 2 diabetes, n (%) 1298 (23.3) 1221 (22.8) 77 (33.8) <0.001 1136 (22.2) 956 (21.0) 180 (31.9) <0.001
Depression
Depression score at baseline (PHQ‐9 score) 2.7 ± 3.3 3.6 ± 1.2 13.6 ± 3.8 <0.001 2.29 ± 2.3 2.0 ± 2.1 4.5 ± 2.7 <0.001
Major depressive disorder at baseline (MINI), n (%) 152 (2.8) 75 (1.5) 77 (35.2) <0.001 68 (1.4) 42 (1.0) 26 (4.8) <0.001
Major depressive disorder lifetime (MINI), n (%) 1635 (30.4) 1449 (28.1) 186 (84.5) <0.001 1381 (28.1) 1091 (24.9) 290 (54.1) <0.001
Use of antidepressants at baseline 361 (6.5) 295 (5.5) 66 (28.9) <0.001 282 (5.5) 204 (4.5) 78 (13.8) <0.001
Physicaly activity
Sedentary (min/day) 561.1 ± 100.6 560.3 ± 99.7 581.0 ± 119.3 0.002 559.9 ± 99.1 558.5 ± 98.8 571.0 ± 100.8 0.005
LiPA (min/day) 343.5 ± 94.6 344.7 ± 93.9 316.5 ± 106.6 <0.001 344.9 ± 93.3 346.6 ± 93.0 331.6 ± 94.8 <0.001
MVPA (min/day) 40.1 ± 23.1 40.5 ± 23.1 32.6 ± 21.4 <0.001 40.7 ± 23.2 41.3 ± 23.1 36.0 ± 23.5 <0.001
Transitions (n/day) 54.6 ± 14.3 54.6 ± 14.2 53.6 ± 16.4 0.277 54.7 ± 14.1 54.7 ± 14.0 54.2 ± 14.8 0.400

Note: Results are presented as mean ± standard deviation (SD) or n (%).

Abbreviations: CVD, Cardiovascular diseases; LiPA, Light physical activity; MDD, Major Depressive Disorder; MINI, Mini‐International Neuropsychiatric Interview; MVPA, Moderate‐to‐vigorous physical activity; PHQ‐9, 9‐item Patient Health Questionnaire.